A comparison of oxycodone prolonged-release vs. oxycodone + naloxone prolonged-release after laparoscopic hysterectomy

Acta Anaesthesiologica Scandinavica

Volumn 57, Issue 4, 2013, Pages 509-517

  Comelon, M ^a   Wisloeff Aase, K ^a   Raeder, J ^a,b   Draegni, T ^c   Undersrud, H ^d   Qvigstad, E ^b,c   Bjerkelund, C E ^a   Lenz, H ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d Medical Department   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

NALOXONE PLUS OXYCODONE; OXYCODONE; TARGINIQ; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONSTIPATION; CONTROLLED STUDY; DEMOGRAPHY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG RELEASE; FEMALE; HUMAN; HYSTERECTOMY; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; NAUSEA; PERIOPERATIVE PERIOD; POSTOPERATIVE PAIN; PREMEDICATION; PREOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RESPIRATION DEPRESSION; VOMITING;

ADULT; ANALGESICS, OPIOID; CONSTIPATION; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYSTERECTOMY; LAPAROSCOPY; MIDDLE AGED; NALOXONE; NARCOTIC ANTAGONISTS; OXYCODONE; PAIN, POSTOPERATIVE; PROSPECTIVE STUDIES;

EID: 84876290715     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/aas.12051     Document Type: Article

References (21)

1. Lenz H, Sandvik L, Qvigstad E, Bjerkelund CE, Raeder J. A comparison of intravenous oxycodone and intravenous morphine in patient-controlled postoperative analgesia after laparoscopic hysterectomy. Anesth Analg 2009; 109: 1279-83.
2. Kalso E. Oxycodone. J Pain Symptom Manage 2005; 29: S47-S56.
3. Avouac J, Gossec L, Dougados M. Efficacy and safety of opioids for osteoarthritis: a meta-analysis of randomized controlled trials. Osteoarthritis Cartilage 2007; 15: 957-65.
4. Davies A, Zeppetella G, Andersen S, Damkier A, Vejlgaard T, Nauck F, Radbruch L, Sjoelund KF, Stenberg M, Buchanan A. Multi-centre European study of breakthrough cancer pain: pain characteristics and patient perceptions of current and potential management strategies. Eur J Pain 2011; 15: 756-63.
5. Gaskell H, Derry S, Moore RA, McQuay HJ. Single dose oral oxycodone and oxycodone plus paracetamol (acetaminophen) for acute postoperative pain in adults. Cochrane Database Syst Rev 2009; (3): CD002763.
6. Pöyhiä R, Seppälä T, Olkkola KT, Kalso E. The pharmacoki-netics and metabolism of oxycodone after intramuscular and oral administration to healthy subjects. Br J Clin Pharmacol 1992; 33: 617-21.
7. Pappagallo M. Incidence, prevalence, and management of opioid bowel dysfunction. Am J Surg 2001; 182: S11-S18.
8. Bell TJ, Panchal SJ, Miaskowski C, Bolge SC, Milanova T, Williamson R. The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European patient survey (PROBE 1). Pain Med 2009; 10: 35-42.
9. Ræder JC, Steine S, Vatsgar TT. Oral ibuprofen versus paracetamol plus codeine for analgesia after ambulatory surgery. Anesth Analg 2001; 92: 1470-2.
10. Kurz A, Sessler DI. Opioid-induced bowel dysfunction: pathophysiology and potential new therapies. Drugs 2003; 63: 649-71.
11. Kehlet H, Holte K. Review of postoperative ileus. Am J Surg 2001; 182: S3-S10.
12. Smith K, Hopp M, Mundin G, Bond S, Bailey P, Woodward J, Bell D. Low absolute bioavailability of oral naloxone in healthy subjects. Int J Clin Pharmacol Ther 2012; 50: 360-7. doi: 10.5414/CP201646 epub: March 5, 2012.
13. Vondrackova D, Leyendecker P, Meissner W, Hopp M, Szombati I, Hermanns K, Ruckes C, Weber S, Grothe B, Fleischer W, Reimer K. Analgesic efficacy and safety of oxy-codone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain. J Pain 2008; 9: 1144-54.
14. Löwenstein O, Leyendecker P, Hopp M, Schutter U, Rogers PD, Uhl R, Bond S, Kremers W, Nichols T, Krain B, Reimer K. Combined prolonged-release oxycodone and naloxone improves bowel function in patients receiving opioids for moderate-to-severe non-malignant chronic pain: a randomised controlled trial. Expert Opin Pharmacother 2009; 10: 531-43.
15. Nadstawek J, Leyendecker P, Hopp M, Ruckes C, Wirz S, Fleischer W, Reimer K. Patient assessment of a novel therapeutic approach for the treatment of severe, chronic pain. Int J Clin Pract 2008; 62: 1159-67.
16. Meissner W, Leyendecker P, Mueller-Lissner S, Nadstawek J, Hopp M, Ruckes C, Wirz S, Fleischer W, Reimer K. A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation. Eur J Pain 2009; 13: 56-64.
17. Ahmedzai SH, Nauck F, Bar-Sela G, Bosse B, Leyendecker P, Hopp M. A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe chronic cancer pain. Palliat Med 2012; 26: 50-60.
18. Lenz H, Raeder J, Hoeymork SC. Administration of fentanyl before remifentanil-based anaesthesia has no influence on post-operative pain or analgesic consumption. Acta Anaes-thesiol Scand 2008; 52: 149-54.
19. Ueberall MA, Müller-Lissner S, Buschmann-Kramm C, Bosse B. The Bowel Function Index for evaluating constipation in pain patients: definition of a reference range for a non-constipated population of pain patients. J Int Med Res 2011; 39: 41-50.
20. Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 1997; 32: 920-4.
21. Raeder JC, Mjaaland O, Aasboe V, Groegaard B, Buanes T. Desflurane versus propofol maintenance for outpatient laparoscopic cholecystectomy. Acta Anaesthesiol Scand 1998; 42: 106-10.